Sign in

CIK 0001815442

  • Large accelerated filer

Kymera Therapeutics, Inc.

Sign in to watch
Ticker
KYMR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812992166
Phone
+1 857-285-5314
Business address
500 NORTH BEACON STREET, 4TH FLOOR, WATERTOWN, MA, 02472
Former names
Kymera Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,158,214
in 2 filings, $3.4M under 10b5-1 plans

Net −$4,158,214. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 68 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-12-14 Atlas Venture Fund X, L.P. 10% owner Sale −54,737 $32.33 $1.8M 5,096,818
2022-12-14 Atlas Venture Fund X, L.P. 10% owner Sale −13,997 $33.34 $467K 5,082,821
2022-12-14 Atlas Venture Fund X, L.P. 10% owner Sale −13,335 $34.02 $454K 5,069,486
2022-12-14 Atlas Venture Fund X, L.P. 10% owner Sale −31,584 $30.28 $956K 969,833
2022-12-14 Atlas Venture Fund X, L.P. 10% owner Sale −28,329 $31.44 $891K 941,504
2022-12-14 Atlas Venture Fund X, L.P. 10% owner Sale −15,324 $32.33 $495K 926,180
2022-12-14 Atlas Venture Fund X, L.P. 10% owner Sale −3,919 $33.34 $131K 922,261
2022-12-14 Atlas Venture Fund X, L.P. 10% owner Sale −3,733 $34.02 $127K 918,528
2022-12-08 Mainolfi Nello Chief Executive Officer Exercise or conversion +10,000 $2.08 $21K 573,700
2022-12-08 Mainolfi Nello Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy) −10,000 18,725
2022-11-03 Booth Bruce Director Sale −75,312 $30.00 $2.3M 5,365,563
2022-11-03 Booth Bruce Director Sale −21,085 $30.00 $633K 1,001,417
2022-11-03 Atlas Venture Fund X, L.P. 10% owner Sale −75,312 $30.00 $2.3M 5,365,563
2022-11-03 Atlas Venture Fund X, L.P. 10% owner Sale −21,085 $30.00 $633K 1,001,417
2022-11-03 Sandor Victor Director Grant or award · Stock Option (Right to Buy) +24,000 24,000
2022-11-02 Booth Bruce Director Sale −96,581 $30.02 $2.9M 5,440,875
2022-11-02 Booth Bruce Director Sale −27,038 $30.02 $812K 1,022,502
2022-11-02 Atlas Venture Fund X, L.P. 10% owner Sale −96,581 $30.02 $2.9M 5,440,875
2022-11-02 Atlas Venture Fund X, L.P. 10% owner Sale −27,038 $30.02 $812K 1,022,502
2022-11-01 Booth Bruce Director Sale −56,455 $30.57 $1.7M 5,541,183

Page 35 of 41 · 810 trades